| 5 |
Reproductive Factors and Subtypes of Breast Cancer Defined by Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2: A Register-Based Study From Korea
Jung Sun Lee,MinKyung Oh,S.H. Ahn,J.W. Bae,Y.T. Bae,J.G. Bong,K.H. Cha,E.S. Chang,I.T. Chang,J.W. Cho,S.H. Cho,Y.U. Cho,K.J. Choi,M.S. Choi,S.I. Choi,G.S. Goo,S.H. Han,W. Han,S.J. Hong,J.Y. Hwang,T.I. Hyun,Y.J. Jegal,M.G. Im,Y.G. Joh,S.Y. Jun,B.W. Jung,J. Jung,K.H. Jung,P.J. Jung,S.H. Jung,Y.H. Jung,D.H. Kang,H.J. Kang,Y.I. Kang,J.H. Keum,D.Y. Kim,H.J. Kim,J.G. Kim,K.C. Kim,S.C. Kim,Y.S. Kim,B.K. Ko,S.S. Ko,S.H. Koh,B.H. Koo,J.Y. Koo,B.S. Kwak,C.H. Lee,D.H. Lee,E.S. Lee,G.S. Lee,H.D. Lee,K.M. Lee,M.H. Lee,R.A. Lee,S.C. Lee,W. Lee,Y.H. Lee,J.W. Leu,C.H. Lim,B.I. Moon,Y.S. Nam,S.J. Nam,D.Y. Noh,W.C. Noh,S.J. Oh,W.K. Pae,I.W. Paik,N.S. Paik,B.G. Park,C.H. Park,H.B. Park,J.H. Park,K.H. Park,S.J. Park,W.C. Park,Y.K. Park,H.S. Seo,K.H. Seo,Y.J. Seo,Y.S. Sin,B.H. Son,G.S. Son,B .J. Song,K.H. Song,Y.J. Song,Y.J. Suh,J.M. Won,D.H. Woo,D.H. Yang,J.H. Yang,K.Y. Yoo,S.Y. Yoo,H.S. Yoon,J.H. Yoon,S.O. Yoon, Jung Sun Lee, MinKyung Oh, S.H. Ahn, J.W. Bae, Y.T. Bae, J.G. Bong, K.H. Cha, E.S. Chang, I.T. Chang, J.W. Cho, S.H. Cho, Y.U. Cho, K.J. Choi, M.S. Choi, S.I. Choi, G.S. Goo, S.H. Han, W. Han, S.J. Hong, J.Y. Hwang, T.I. Hyun, Y.J. Jegal, M.G. Im, Y.G. Joh, S.Y. Jun, B.W. Jung, J. Jung, K.H. Jung, P.J. Jung, S.H. Jung, Y.H. Jung, D.H. Kang, H.J. Kang, Y.I. Kang, J.H. Keum, D.Y. Kim, H.J. Kim, J.G. Kim, K.C. Kim, S.C. Kim, Y.S. Kim, B.K. Ko, S.S. Ko, S.H. Koh, B.H. Koo, J.Y. Koo, B.S. Kwak, C.H. Lee, D.H. Lee, E.S. Lee, G.S. Lee, H.D. Lee, K.M. Lee, M.H. Lee, R.A. Lee, S.C. Lee, W. Lee, Y.H. Lee, J.W. Leu, C.H. Lim, B.I. Moon, Y.S. Nam, S.J. Nam, D.Y. Noh, W.C. Noh, S.J. Oh, W.K. Pae, I.W. Paik, N.S. Paik, B.G. Park, C.H. Park, H.B. Park, J.H. Park, K.H. Park, S.J. Park, W.C. Park, Y.K. Park, H.S. Seo, K.H. Seo, Y.J. Seo, Y.S. Sin, B.H. Son, G.S. Son, B .J. Song, K.H. Song, Y.J. Song, Y.J. Suh, J.M. Won, D.H. Woo, D.H. Yang, J.H. Yang, K.Y. Yoo, S.Y. Yoo, H.S. Yoon, J.H. Yoon, S.O. Yoon,
Vol. 14 pp. 426-434
|
2014 |
225
|
| 6 |
Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.
S. Kahraman, E. Erul, O. Gumusay, D.C. Guven, Sercan Aksoy, G. Basaran, M. Seyyar, E. Sahin, D. Çabuk, E. Bayram, S. Paydaş, B. Demirel, A. Yaren, B. Gulbagci, I. Hacibekiroglu, N. K. Baytemur, U. Demirci, S. E. Davarci, H. Demir, Eda Eylemer Mocan, Ozlem Dogan, E. Çılbır, Alper Yaşar, I. V. Bayoglu, M. Hızal, E. Kayıkçıoğlu, Bulent Cetin, O. Acar, A. Erdoğan, Merve Keskinkilic, T. Yavuzşen, O. Unal, F. Yılmaz, Mutlu Doğan, S. Orhan, E. Çubukçu, C. Erol, T. Şakalar, O. Dulgar, Yusuf Karakaş, Gulhan Ozkanli, B. Duman, D. Işık, Muge Karaoglanoglu, S. Okutur, N. Yıldırım, E. Aydin, B. Uluç, M. Keser, Burak Bilgin, Asude Aksoy, Onder Eren, N. O. Kalkan, M. Er, Hakan Yucel, V. Sunar, N. Paksoy, D. Aydın, N. Turhal, S. Menekşe, E. Kut, M. Aykan, Ozlem Ozdemir, M. Ozcelik, Y. Iriagac, F. Selçukbiricik, Ali Inal, Nuri Karadurmus, M. Akıncı, M. Şendur
|
2025 |
44
|